These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 2493806

  • 1. Determination of the LDL receptor binding capacity of human lymphocytes by immunocytofluorimetric assay.
    Benhamamouch S, Kuznierz JP, Agnani G, Marzin D, Lecerf JM, Fruchart JC, Clavey V.
    Biochim Biophys Acta; 1989 Mar 14; 1002(1):45-53. PubMed ID: 2493806
    [Abstract] [Full Text] [Related]

  • 2. Reconstitution of LDL with lipophilic fluorescein derivatives: quantitative analysis of the receptor activity of human lymphocytes.
    Krieger M, Ho YK, Falck JR.
    J Recept Res; 1983 Mar 14; 3(3):361-75. PubMed ID: 6312035
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of the specific binding of human lactotransferrin to human peripheral-blood phytohaemagglutinin-stimulated lymphocytes by fluorescein labelling and location of the binding site.
    Legrand D, Mazurier J, Maes P, Rochard E, Montreuil J, Spik G.
    Biochem J; 1991 Jun 15; 276 ( Pt 3)(Pt 3):733-8. PubMed ID: 1648350
    [Abstract] [Full Text] [Related]

  • 8. Advantages and versatility of fluorescence-based methodology to characterize the functionality of LDLR and class mutation assignment.
    Etxebarria A, Benito-Vicente A, Alves AC, Ostolaza H, Bourbon M, Martin C.
    PLoS One; 2014 Jun 15; 9(11):e112677. PubMed ID: 25386756
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Up-regulation of LDL-receptor expression by LDL-immunoapheresis in patients with familial hypercholesterolemia.
    Streicher J, Valent P, Schmidt H, Sengölge G, Wagner O, Strobl W, Hörl WH, Derfler K.
    J Investig Med; 1999 Sep 15; 47(8):378-87. PubMed ID: 10510590
    [Abstract] [Full Text] [Related]

  • 12. Short time bleaching of fluorescein isothiocyanate. A possible parameter for the specific binding of conjugates in immunofluorescence.
    Schauenstein K, Böck G, Wick G.
    J Histochem Cytochem; 1980 Sep 15; 28(9):1029-31. PubMed ID: 6774008
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Low density lipoprotein degradation by mononuclear cells from normal and dyslipoproteinemic subjects.
    Lees AM, Lees RS.
    Proc Natl Acad Sci U S A; 1983 Aug 15; 80(16):5098-102. PubMed ID: 6576379
    [Abstract] [Full Text] [Related]

  • 16. Expression of low density lipoprotein receptors in lymphoblasts induced by anti-CD3 antibody in patients with hypercholesterolemia.
    Shin BM, Park YB, Kim JQ.
    J Korean Med Sci; 1995 Oct 15; 10(5):318-23. PubMed ID: 8750056
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Pravastatin increases the activity pf the LDL receptors in lymphocytes of individuals with heterozygous familial hypercholesterolemia].
    Alvarez-Sala LA, Mata P, Blázquez E, Garrido JA, Ordovás JM, Rubio MJ, de Oya M.
    Rev Clin Esp; 1997 May 15; 197(5):317-22. PubMed ID: 9280964
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.